Jeff Barlow Sells 17,811 Shares of Molina Healthcare (NYSE:MOH) Stock

Posted by Brenda Bartman on May 15th, 2026

Molina Healthcare, Inc (NYSE:MOH – Get Free Report) insider Jeff Barlow sold 17,811 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the transaction, the insider owned 67,175 shares in the company, valued at approximately $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Molina Healthcare Stock Performance

Molina Healthcare stock opened at $186.72 on Friday. The stock’s 50-day moving average is $156.26 and its 200-day moving average is $158.72. The company has a market cap of $9.73 billion, a price-to-earnings ratio of 55.24 and a beta of 0.85. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. Molina Healthcare, Inc has a 12 month low of $121.06 and a 12 month high of $327.68.

Molina Healthcare (NYSE:MOH – Get Free Report) last posted its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The business had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. During the same quarter last year, the firm earned $6.08 earnings per share. The company’s revenue for the quarter was down 3.1% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Equities analysts anticipate that Molina Healthcare, Inc will post 5.23 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on MOH. The Goldman Sachs Group lowered their target price on Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a research note on Wednesday, February 11th. Barclays increased their target price on Molina Healthcare from $133.00 to $161.00 and gave the company an “underweight” rating in a research note on Friday, April 24th. Bank of America upgraded Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price for the company in a research note on Wednesday, April 29th. Cantor Fitzgerald increased their target price on Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a research note on Monday. Finally, Morgan Stanley increased their target price on Molina Healthcare from $128.00 to $146.00 and gave the company an “equal weight” rating in a research note on Friday, April 24th. Three equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, Molina Healthcare currently has a consensus rating of “Hold” and a consensus price target of $174.53.

Get Our Latest Analysis on Molina Healthcare

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Torren Management LLC bought a new position in Molina Healthcare during the 4th quarter worth approximately $26,000. Miller Global Investments LLC bought a new stake in shares of Molina Healthcare in the 4th quarter worth approximately $27,000. MUFG Securities EMEA plc bought a new stake in shares of Molina Healthcare in the 2nd quarter worth approximately $48,000. Cromwell Holdings LLC lifted its holdings in shares of Molina Healthcare by 211.9% in the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after purchasing an additional 125 shares during the last quarter. Finally, Quarry LP bought a new stake in shares of Molina Healthcare in the 4th quarter worth approximately $32,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

(Get Free Report)

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.